ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Leilei Ying

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5104290628. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting miR-30d-5p/MARCH8. Co-author DOI 10.1016/j.heliyon.2024.e33835 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xinhong He · 1 shared paper, 2024 · strength 0.20
- Paper OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting … DOI 10.1016/j.heliyon.2024.e33835 ↗
Lichao Xu · 1 shared paper, 2024 · strength 0.20
- Paper OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting … DOI 10.1016/j.heliyon.2024.e33835 ↗
Wentao Li · 1 shared paper, 2024 · strength 0.20
- Paper OIP5-AS1 enhances the malignant characteristics and resistance to chemotherapy of pancreatic cancer cells by targeting … DOI 10.1016/j.heliyon.2024.e33835 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.